Met Life Investment Management, LLC Ngm Biopharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$2.44 - $4.53 $52,372 - $97,231	21,464 New	21,464 $55,000
Q2 2023 Aug 10, 2023	BUY	$2.44 - $4.53 $32,839 - $60,969	13,459 Added 168.13%	21,464 $55,000
Q1 2023 May 09, 2024	BUY	$3.72 - $5.4 $29,778 - $43,227	8,005 New	8,005 $32.7 Million
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $38,301 - $55,598	-10,296 Reduced 56.26%	8,005 $32,000
Q4 2022 Jun 14, 2023	BUY	$3.41 - $12.93 $35,109 - $133,127	10,296 Added 128.62%	18,301 $91,000
Q3 2022 Jun 14, 2023	BUY	$12.59 - $17.67 $129,626 - $181,930	10,296 Added 128.62%	18,301 $239,000
Q2 2022 Jun 20, 2023	BUY	$10.58 - $17.5 $108,931 - $180,180	10,296 Added 128.62%	18,301 $234,000
Q1 2022 May 10, 2024	BUY	$13.81 - $18.6 $252,736 - $340,398	18,301 New	18,301 $279,000
Q1 2022 Jun 20, 2023	BUY	$13.81 - $18.6 $142,187 - $191,505	10,296 Added 128.62%	18,301 $279,000
Q1 2022 Mar 22, 2023	BUY	$13.81 - $18.6 $91,643 - $123,429	6,636 Added 56.89%	18,301 $279,000
Q1 2022 May 12, 2022	BUY	$13.81 - $18.6 $91,643 - $123,429	6,636 Added 56.89%	18,301 $279,000
Q4 2021 Jun 21, 2023	BUY	$17.26 - $22.02 $63,171 - $80,593	3,660 Added 45.72%	11,665 $206,000
Q3 2021 Jun 21, 2023	BUY	$20.15 - $26.19 $73,749 - $95,855	3,660 Added 45.72%	11,665 $245,000
Q2 2021 Jun 21, 2023	BUY	$15.06 - $30.03 $55,119 - $109,909	3,660 Added 45.72%	11,665 $230,000
Q1 2021 May 17, 2024	BUY	$24.99 - $31.93 $291,508 - $372,463	11,665 New	11,665 $339,000
Q1 2021 Jun 26, 2023	BUY	$24.99 - $31.93 $91,463 - $116,863	3,660 Added 45.72%	11,665 $339 Million
Q4 2020 Jun 22, 2023	BUY	$16.21 - $31.44 $59,328 - $115,070	3,660 Added 45.72%	11,665 $353,000
Q3 2020 Jun 26, 2023	BUY	$15.59 - $19.97 $57,059 - $73,090	3,660 Added 45.72%	11,665 $185,000
Q2 2020 May 24, 2024	BUY	$11.97 - $23.47 $139,630 - $273,777	11,665 New	11,665 $230 Million
Q2 2020 Jun 26, 2023	BUY	$11.97 - $23.47 $43,810 - $85,900	3,660 Added 45.72%	11,665 $230,000
Q1 2020 Jul 12, 2023	BUY	$10.0 - $19.51 $36,600 - $71,406	3,660 Added 45.72%	11,665 $143,000
Q4 2019 Jul 12, 2023	BUY	$9.97 - $20.28 $36,490 - $74,224	3,660 Added 45.72%	11,665 $215,000
Q4 2019 Mar 22, 2023	SELL	$9.97 - $20.28 $66,160 - $134,578	-6,636 Reduced 36.26%	11,665 $215,000
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $116,300 - $236,566	11,665 New	11,665 $216,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account